A combination of two targeted therapies reduces tumors in treatment-resistant Ewing's sarcoma, a bone cancer that mainly strikes children, adolescents and young adults.
Results of the phase I clinical trial of the paired drugs were announced today at a news briefing at the AACR Annual Meeting 2012 by Aung Naing, M.D., assistant professor in MD Anderson's Department of Investigational Cancer Therapeutics. He presents the study...
Abnormal activation or production of four proteins involved in translation, the final step of creating other proteins, are associated with...
An innovative approach to targeting the blood vessels that support neuroendocrine tumors of the pancreas has earned the support of a major...
The American Association for Cancer Research will present its sixth annual AACR Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research to John Mendelsohn, M.D., at the association's annual meeting opening session this Sunday in Chicago.
Mendelsohn is co-director of MD Anderson's Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy (IPCT) and was president of MD Anderson from...
We have known for the past two decades that aspirin and non-steroidal anti-inflammatory drug (NSAID) use reduces the risk of colorectal and...
Researchers have caught two molecular signaling networks engaged in "crosstalk" that undermines attempts to successfully target cancer-promoting...
Tobacco use has long been known to cause lung cancer and increased morbidity in smokers. A study sponsored by the National Cancer Institute...
At an early age, children are naturally physically active, full of energy and often find joy in running and jumping in an unstructured environment...
Myelofibrosis, a lethal bone marrow malignancy, comes with especially debilitating symptoms that sap a patient's quality of life.
...